OralCare Journal of Clinical Oral Medicine and Maxillofacial Surgery
Management of Fetal Mesenchymal Hamartoma of the Liver: A Case Report
Abstract
Jarray L, Ben Ahmed Y, Marzouki M, Charieg A, Nouira F and Jlidi S
Introduction Hepatic mesenchymal hamartomas are rare benign tumours of the liver. Although most cases are discovered after birth, a few antenatal diagnoses have been reported in the literature.
Case Presentation This is an 8-month-old girl with a prenatal diagnosis of a non-vascular anechogenic intra-abdominal mass, 30 mm in size, without septum, discovered during the third-trimester ultrasound. She was born at term by caesarean section due to macrosomia and gestational diabetes.
No Palpable Mass on Clinical Examination was Found Abdominal ultrasound revealed the presence of a cystic mass in anterior of the left hepatic lobe with transsonic content, without clean wall or tissue component, with cloisons, some of which are thickened, measuring 79*40*70mm. A CT scan showed an exophytic cystic mass of the left liver in segments 2, 3 and 4. It measured 83*37*84 mm. It was next to the liver’s left portal branch and away from the hepatic veins. On a clinical X-ray, the left liver’s mesenchymatous hamartoma appears. Tumour markers were negative.
The patient underwent surgery at 8-month-old via a right subcutaneous incision and was found to have a thin-walled cystic mass. This mass was exophytic in relation with segments II and III, measuring 8cm with a cleavage plane, and the entire mass was resected.
Conclusion Mesenchymal hamartoma is a rare benign pathology that can be diagnosed antenatally.
Complete resection is the recommended therapeutic approach, with a favorable outcome.
Conclusions This study showed that HDL-C, lipid metabolites, including hexadecanedioate, tetradecanedioate, and 1-arachidonoyl- glycerophosphoinositol, had causal effect with PBC risk. Targeting ABCG5/ABCG8 may reduce PBC risk.